Pfizer (PFE) executive Andrew Baum, hired in 2024 as its Chief Strategy and Innovation Officer to overhaul the company’s strategic direction, is leaving the drugmaker later this year, according to a ...
The MarketWatch News Department was not involved in the creation of this content. TEL AVIV, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in ...
Andrew Baum, a former Citi analyst, has left his role as Pfizer's executive vice president and chief strategy and innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results